000 01306 a2200313 4500
005 20250514214302.0
264 0 _c20050526
008 200505s 0 0 eng d
022 _a0009-8981
024 7 _a10.1016/j.cccn.2004.09.019
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCosta, Lucio G
245 0 0 _aMeasurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicity.
_h[electronic resource]
260 _bClinica chimica acta; international journal of clinical chemistry
_cFeb 2005
300 _a37-47 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Review
650 0 4 _aAnimals
650 0 4 _aAryldialkylphosphatase
_xchemistry
650 0 4 _aBiomarkers
_xmetabolism
650 0 4 _aGenetic Predisposition to Disease
650 0 4 _aHumans
650 0 4 _aNeurotoxicity Syndromes
_xenzymology
650 0 4 _aOrganophosphates
_xtoxicity
700 1 _aCole, Toby B
700 1 _aVitalone, Annabella
700 1 _aFurlong, Clement E
773 0 _tClinica chimica acta; international journal of clinical chemistry
_gvol. 352
_gno. 1-2
_gp. 37-47
856 4 0 _uhttps://doi.org/10.1016/j.cccn.2004.09.019
_zAvailable from publisher's website
999 _c15332354
_d15332354